ABC | Volume 112, Nº1, Janeiro 2019

Elias Neto et al C/DAVD – Diagnóstico e tratamento Arq Bras Cardiol. 2019; 112(1):91-103 Artigo de Revisão Contribuição dos autores Concepção e desenho da pesquisa e obtenção de dados: Elias Neto J, Tonet J, Fontaine G; análise e interpretação dos dados e revisão crítica do manuscrito quanto ao conteúdo intelectual importante: Elias Neto J, Tonet J, Frank R; análise estatística, obtenção de financiamento e redação do manuscrito: Elias Neto J. Potencial conflito de interesses Declaro não haver conflito de interesses pertinentes. Fontes de financiamento Opresente estudo não teve fontes de financiamento externas. Vinculação acadêmica Não há vinculação deste estudo a programas de pós‑graduação. 1. Fontaine G, Chen HS. Arrhythmogenic right ventricular dysplasia back in force. Am J Cardiol. 2014;113(10):1735-9. 2. Elias J, Tonet J, Frank R, Fontaine G. Arrhythmogenic right ventricular dysplasia. Arq Bras Cardiol. 1998;70(6):449-56. 3. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384-98. 4. Wang W, James CA, Calkins H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. Europace. 2018 Apr 23; [Epub ahead of print]. Disponível em: https:// academic.oup.com/europace/advance-article 5. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61-72. 6. Calkins H. Arrhythmogenic right ventricular dysplasia/cardiomyopathy - three decades of progress. Circ J. 2015;79(5):901-13. 7. Philips B, Cheng A. 2015 update on the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol. 2016;31(1):46-56. 8. Asimaki A, Kleber AG, Saffitz JE. Pathogenesis of arrhythmogenic cardiomyopathy. Can J Cardiol. 2015;31(11):1313-24. 9. Zhang L, Liu L, Kowey PR, Fontaine GH. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10(3):237-45. 10. Marcus F, Edson S, Towbin JA. Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol. 2013;61(19):1945-8. 11. Mizusawa Y. . Recent advances in genetic testing and counseling for inherited arrhythmias. J Arrhythm. 2016;32(5):389-97. 12. van der Zwaag PA, Jongbloed JD, van den Berg MP, van der Smagt JJ, Jongbloed R, Bikker H, et al. A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. HumMutat. 2009;30(9):1278-83. 13. Corrado D, Zorzi A, Cerrone M, Mongillo RM, Bauce B, Delmar M. Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada Syndrome: new insights from molecular biology and clinical implications. Circ Arrhythm Electrophysiol. 2016;9(4):e003631. 14. Bhonsale A, Riele ASJM, Sawant AC, Groeneweg JÁ, James CA, Murray B, et al. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.Heart Rhythm. 2017;14(6):883-91. 15. Ruwald AC, Marcus F, Estes NA 3rd, Link M, McNitt S, Polonsky B, et al. Association of competitive and recreational sport participationwith cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2015;36(27):1735-43. 16. Pinamonti B, Brun F, Mestroni L, SinagraG. Arrhythmogenic right ventricular cardiomyopathy: from genetics to diagnostic and therapeutic challenges. World J Cardiol. 2014;6(12):1234-44. 17. Liu T, Pursnani A, SharmaUC, Vorasettakarnkij Y, Verdini D, Deeprasertkul P, et al. Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Magn Reson. 2014 Jul 4;16:47. 18. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533-41. 19. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52(25):2175-87. 20. Castanos Gutiérrez SL, Kamel IR, Zimmerman SL. Current concepts on diagnosisandprognosisofarrhythmogenicrightventricularcardiomyopathy/ dysplasia. J Thorac Imaging. 2016;31(6):324-35. 21. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533-41. 22. Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res. 2017;121(7):784-802. 23. Li GL, Saguner AM, Fontaine GH, Frank R. Epislon waves: Milestones in the discovery and progress. Ann Noninvasive Electrocardiol. 2018;23(6):e12571. 24. Tonet JL, Castro-Miranda R, Iwa T, Poulain F, Frank R, Fontaine GH. Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 1991;67(13):1153. 25. Camm CF, James CA, Tichnell C, Murray B, Bhonsale A, te Riele AS, et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2013;10(11):1661-8. 26. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia Circulation. 2003;108(25):3084-91. 27. Chung FP, Llin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, et al. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiol. 2015;65(6):441-50. Referências 12